Company Profiles

driven by the PitchBook Platform

Drais Pharmaceuticals

Description

Developer of therapeutic treatment drugs. The company engages in the development of therapeutic treatments that address unmet medical needs and provide significant benefits over currently available therapies.

2007

Founded

PRIVATE

Status

11-50

Employees

Series A

Latest Deal Type

$20M

Latest Deal Amount

$20M

Total Amount Raised

Description

Developer of therapeutic treatment drugs. The company engages in the development of therapeutic treatments that address unmet medical needs and provide significant benefits over currently available therapies.

Website:

www.draispharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

520 US Highway 22 Suite 201 Bridgewater, NJ 08807United States +1 (908) 895-1200
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Drais Pharmaceuticals's full profile, request a free trial.

Drais Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Drais Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Drais Pharmaceuticals Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
InterWest PartnersVenture CapitalMinority000 0000000 0000
Sutter Hill VenturesVenture CapitalMinority000 0000000 0000
InterWest Partners Venture Capital
Sutter Hill Ventures Venture Capital

Drais Pharmaceuticals Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Stephen Waters Ph.DVice President, Nonclinical & Translational Development and Chief Scientific Officer
Christine MulhauserDirector
Deborah HopperDirector, Administration
Christopher Del MastroDirector, Finance & Contracts
Rudy LucekExecutive Vice President, Regulatory Affairs and Quality Control
Stephen Waters Ph.D Vice President, Nonclinical & Translational Development and Chief Scientific Officer
Christine Mulhauser Director
Deborah Hopper Director, Administration
Christopher Del Mastro Director, Finance & Contracts
Rudy Lucek Executive Vice President, Regulatory Affairs and Quality Control

Drais Pharmaceuticals Board Members (3)

NameRepresentingRoleSinceContact
Info
Arnold Oronsky Ph.DInterWest PartnersManaging Director000 0000
Jeffrey Bird Ph.DSutter Hill VenturesManaging Director000 0000
Robert Desjardins MDDrais PharmaceuticalsBoard Member000 0000
Arnold Oronsky Ph.D Managing Director InterWest Partners
Jeffrey Bird Ph.D Managing Director Sutter Hill Ventures
Robert Desjardins MD Board Member Drais Pharmaceuticals
Request full access to PitchBook